taxonomy (3)
protein (8)
source (2)
structure (1)
composition (1)
disease (0)
reference (3)
site (8)
peptide (2)
- Immunoglobulin heavy constant gamma 1 (Trastuzumab) / Homo sapiens P01857
- Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant A121N / Homo sapiens P01857
- Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L115N / Homo sapiens P01857
- Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L177N / Homo sapiens P01857
- Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L182N / Homo sapiens P01857
- Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant Q178N / Homo sapiens P01857
- Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant T198N / Homo sapiens P01857
- Immunoglobulin kappa light chain (Trastuzumab) mutant Q160N / Homo sapiens P0DOX7
Protein
- Colon (UBERON_0001155)
- HEK293-F (CVCL_6642)
Source
- N-Linked / Complex / Structure 11110
Reported structure
- Hex:4 HexNAc:4 dHex:1 (avg mass : 1625.5079 )
Composition
Disease
- N-Glycosylation in isolated rat nerve terminals (2021 - Matthies I, Abrahams JL, Jensen P, Oliveira T, Kolarich D, Larsen MR) / Status : Reviewed
- Toward robust N-glycomics of various tissue samples that may contain glycans with unknown or unexpected structures. (2021 - Suzuki N, Abe T, Hanzawa K, Natsuka S) / Status : Reviewed
- Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity. (2021 - Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V) / Status : Reviewed
Reference
-
Immunoglobulin heavy constant gamma 1 (Trastuzumab) / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant A121N / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L115N / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L177N / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L182N / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant Q178N / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant T198N / Homo sapiens
- Undefined site
-
Immunoglobulin kappa light chain (Trastuzumab) mutant Q160N / Homo sapiens
- Undefined site
Reported glycosite
- NSGALTSGVHTFPAVLQSSGLY (22aa)
- P01857     Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L182N / Homo sapiens
- 182:L→N
- P01857     Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant Q178N / Homo sapiens
- 178:Q→N
- P01857     Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L177N / Homo sapiens
- 177:L→N
- SLSSVVTVPSSSLGTQTY (18aa)
Mass spectrometry observed peptide
-
- N-Linked / Complex
(avg mass : 1625.5079)
- Colon (UBERON_0001155)
- HEK293-F (CVCL_6642)
- N-Glycosylation in isolated rat nerve terminals (2021 - Matthies I, Abrahams JL, Jensen P, Oliveira T, Kolarich D, Larsen MR) / Status : Reviewed
- Toward robust N-glycomics of various tissue samples that may contain glycans with unknown or unexpected structures. (2021 - Suzuki N, Abe T, Hanzawa K, Natsuka S) / Status : Reviewed
- Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity. (2021 - Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V) / Status : Reviewed
-
Immunoglobulin heavy constant gamma 1 (Trastuzumab) / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant A121N / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L115N / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L177N / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L182N / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant Q178N / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant T198N / Homo sapiens
- Undefined site
-
Immunoglobulin kappa light chain (Trastuzumab) mutant Q160N / Homo sapiens
- Undefined site
- NSGALTSGVHTFPAVLQSSGLY (22aa)
- P01857     Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L182N / Homo sapiens
- 182:L→N
- P01857     Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant Q178N / Homo sapiens
- 178:Q→N
- P01857     Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L177N / Homo sapiens
- 177:L→N
- SLSSVVTVPSSSLGTQTY (18aa)
Source
Reference
Reported glycosite
Mass spectrometry observed peptide
3D structure from GLYCAM
- N-Linked / Complex
(avg mass : 1625.5079)